东富龙收盘上涨1.06%，滚动市盈率68.31倍，总市值102.16亿元

Company Overview - Dongfulong Technology Group Co., Ltd. specializes in providing pharmaceutical process, core equipment, and system engineering solutions for global pharmaceutical companies [1] - The main product segments include bioprocessing, formulation, engineering solutions, and food equipment engineering [1] Financial Performance - For Q1 2025, the company reported revenue of 1.137 billion yuan, representing a year-on-year increase of 2.58% [1] - The net profit for the same period was 20.1326 million yuan, showing a significant year-on-year decline of 68.87% [1] - The gross profit margin stood at 24.45% [1] Market Position - As of July 16, the closing stock price was 13.34 yuan, with a PE ratio of 68.31, marking a new low in 71 days [1] - The total market capitalization is 10.216 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 51.87, with a median of 37.48, placing Dongfulong at the 96th position in the industry ranking [1][2] Institutional Holdings - As of Q1 2025, seven institutions hold shares in Dongfulong, with a total of 89.388 million shares valued at 1.153 billion yuan [1]